---
figid: PMC2682371__nihms-109898-f0002
figlink: /pmc/articles/PMC2682371/figure/F2/
number: Fig. 2
caption: ErbB proteins are type I transmembrane receptor tyrosine kinases. Each has
  an extracellular region containing two extracellular cysteine-rich domains, a transmembrane
  domain, a short intracellular juxtamembrane region, a tyrosine kinase domain and
  a carboxy-terminal tail. In response to neuregulin 1 (NRG1) stimulation, ErbB proteins
  become dimerized to form homo- and heterodimers, such as ErbB2–ErbB3, ErbB4–ErbB4,
  ErbB2–ErbB4 and ErbB4–epidermal growth factor receptor (EGFR). ErbB2 does not bind
  to NRG1 (indicated by the black crosses) but has an active kinase domain; ErbB3
  binds to NRG1 but has an impaired tyrosine kinase domain (indicated by the purple
  cross). Therefore, ErbB2 and ErbB3 need to form heterodimers with each other or
  with ErbB4 to be functional, whereas ErbB4 homodimers can bind to NRG1 and become
  activated. Activation of the tyrosine kinase domains leads to auto- and trans-phosphorylation
  of the intracellular domains, generating docking sites for the adaptor proteins
  Grb2 and Shc, which activate the Raf–MEK–ERK pathway, and for the p85 subunit of
  PI3K (indicated in the figure for the ErbB2–ErbB3 heterodimer), which activates
  the PI3K pathway and subsequently mTOR-dependent protein synthesis. NRG1 activates
  CDK5, which is also stimulated by neuronal activity. EGFR does not bind to NRG1.
  Its downstream pathways include ones that involve JNK, Src, Abl, and PKC in addition
  to ones that involve ERK and PI3K/Akt.
pmcid: PMC2682371
papertitle: Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.
reftext: Lin Mei, et al. Nat Rev Neurosci. ;9(6):437-452.
pmc_ranked_result_index: '73024'
pathway_score: 0.9531008
filename: nihms-109898-f0002.jpg
figtitle: ErbB proteins are type I transmembrane receptor tyrosine kinases
year: ''
organisms: Homo sapiens
ndex: d3297233-deef-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2682371__nihms-109898-f0002.html
  '@type': Dataset
  description: ErbB proteins are type I transmembrane receptor tyrosine kinases. Each
    has an extracellular region containing two extracellular cysteine-rich domains,
    a transmembrane domain, a short intracellular juxtamembrane region, a tyrosine
    kinase domain and a carboxy-terminal tail. In response to neuregulin 1 (NRG1)
    stimulation, ErbB proteins become dimerized to form homo- and heterodimers, such
    as ErbB2–ErbB3, ErbB4–ErbB4, ErbB2–ErbB4 and ErbB4–epidermal growth factor receptor
    (EGFR). ErbB2 does not bind to NRG1 (indicated by the black crosses) but has an
    active kinase domain; ErbB3 binds to NRG1 but has an impaired tyrosine kinase
    domain (indicated by the purple cross). Therefore, ErbB2 and ErbB3 need to form
    heterodimers with each other or with ErbB4 to be functional, whereas ErbB4 homodimers
    can bind to NRG1 and become activated. Activation of the tyrosine kinase domains
    leads to auto- and trans-phosphorylation of the intracellular domains, generating
    docking sites for the adaptor proteins Grb2 and Shc, which activate the Raf–MEK–ERK
    pathway, and for the p85 subunit of PI3K (indicated in the figure for the ErbB2–ErbB3
    heterodimer), which activates the PI3K pathway and subsequently mTOR-dependent
    protein synthesis. NRG1 activates CDK5, which is also stimulated by neuronal activity.
    EGFR does not bind to NRG1. Its downstream pathways include ones that involve
    JNK, Src, Abl, and PKC in addition to ones that involve ERK and PI3K/Akt.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAP2K2
  - RAF1
  - MAPK3
  - STAT4
  - FOS
  - STAT5B
  - PTK2B
  - STAT6
  - MAPK1
  - MYC
  - EXOSC3
  - AKT1
  - ERBB3
  - ERBB4
  - STAT2
  - STAT3
  - STAT5A
  - PRKCH
  - PRKCQ
  - PRKCZ
  - ARAF
  - MTOR
  - MTTP
  - AK1
  - AKT3
  - AKT2
  - JUN
  - EGFR
  - STAT1
  - PRKCE
  - PRKCG
  - PRKCI
  - PIK3CB
  - BRAF
  - KRAS
  - PIK3R2
  - SRC
  - PRKD3
  - NRAS
  - SOST
  - PIK3CG
  - PIK3CA
  - PIK3R6
  - PIK3R1
  - PIK3R4
  - PRKCB
  - PIK3R3
  - PIK3R5
  - PIK3CD
  - PRKCD
  - HRAS
  - PRKCA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: Pyk2
  symbol: PYK2
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: p10
  symbol: p10
  source: hgnc_alias_symbol
  hgnc_symbol: EXOSC3
  entrez: '51010'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ErbB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB4
  symbol: ERBB4
  source: hgnc_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Abl
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: AK-1
  symbol: AK1
  source: hgnc_symbol
  hgnc_symbol: AK1
  entrez: '203'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: c-jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3KP85
  symbol: PI3K_p85
  source: bioentities_symbol
  hgnc_symbol: PIK3R2
  entrez: '5296'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SOST
  symbol: SOST
  source: hgnc_symbol
  hgnc_symbol: SOST
  entrez: '50964'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3KP85
  symbol: PI3K_p85
  source: bioentities_symbol
  hgnc_symbol: PIK3R1
  entrez: '5295'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
